Fumihiro Shoji
Otsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Delayed Descending Thoracic Aortic Laceration Caused by a Posterior Rib Fracture Fragment: A Case Report.
Journal: Surgical case reports
Published: March 16, 2026
Prognostic significance of intratumoral neutrophil extracellular traps in pulmonary pleomorphic carcinoma: comparison with adenocarcinoma.
Journal: BJC reports
Published: January 08, 2026
Intratumoral microbiome is associated with the response to cancer immunotherapy in lung cancer patients with high PD-L1 expression.
Journal: Immuno-oncology technology
Published: November 24, 2025
Optimizing the dissection of small-diameter pulmonary vessels using vessel-sealing systems.
Journal: Scientific reports
Published: May 20, 2025
A Prospective Observational Study Analyzing the Diversity and Specific Composition of the Oral and Gut Microbiota in Lung Cancer Patients.
Journal: Anticancer research
Published: September 14, 2024
The Role of Gut Microbiota in Lung Carcinogenesis and Cancer Immunotherapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 15, 2024
Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
Journal: Cancer medicine
Published: October 13, 2022
Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinoma.
Journal: Investigational new drugs
Published: September 23, 2022
Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer.
Journal: Frontiers in molecular biosciences
Published: September 09, 2022
Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
Journal: Thoracic cancer
Published: August 08, 2022
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.
Journal: Frontiers in oncology
Published: June 10, 2022
Last Updated: 09/26/2026